Senior Director
Foghorn Therapeutics
Currently, Head of Translational Science at Foghorn Therapeutics and driving the Translational Strategy across multiple pre-clinical and clinical programs targeting epigenetic oncology targets in hematological and solid tumors. Prior experiences as Translational Leads at Constellation, Novartis, Pfizer, and Genentech. I received my PhD at UC Berkeley in 2010 in Molecular and Cellular Biology investigating the role of non-coding RNAs in the epigenetic regulation of Drosophila embryonic development.
